NPI: 1558807370 · WATERLOO, IA 50701 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/18/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/18/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,651 | $63K |
| 2019 | 4,252 | $108K |
| 2020 | 8,665 | $270K |
| 2021 | 20,727 | $349K |
| 2022 | 8,462 | $610K |
| 2023 | 3,932 | $330K |
| 2024 | 2,194 | $224K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,157 | 2,228 | $1.88M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1,922 | 150 | $56K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,856 | 537 | $13K |
| J1756 | Injection, iron sucrose, 1 mg | 2,499 | 515 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,060 | 225 | $2K |
| 83970 | 426 | 296 | $903.33 | |
| A4657 | Syringe, with or without needle, each | 4,238 | 1,297 | $555.52 |
| 82728 | 471 | 317 | $326.72 | |
| 83550 | 451 | 304 | $180.43 | |
| 85041 | 1,045 | 647 | $152.51 | |
| 82108 | 52 | 39 | $143.77 | |
| 83540 | 451 | 304 | $136.74 | |
| 85048 | 1,045 | 647 | $128.45 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 36 | 24 | $70.08 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 151 | 63 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 23 | 12 | $0.00 |